+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors



Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors



Clinical Cancer Research 10(16): 5349-5354



In an effort to additionally determine the global patterns of CpG island hypermethylation in sporadic breast cancer, we searched for aberrant promoter methylation at 10 gene loci in 54 primary breast cancer and 10 breast benign lesions. Genomic DNA sodium bisulfate converted from benign and malignant tissues was used as template in methyl-specific PCR for BRCA1, p16, ESR1, GSTP1, TRbeta1, RARbeta2, HIC1, APC, CCND2, and CDH1 genes. The majority of the breast cancer (85%) showed aberrant methylation in at least 1 of the loci tested with half of them displaying 3 or more methylated genes. The highest frequency of aberrant promoter methylation was found for HIC1 (48%) followed by ESR1 (46%), and CDH1 (39%). Similar methylation frequencies were detected for breast benign lesions with the exception of the CDH1 gene (P = 0.02). The analysis of methylation distribution indicates a statistically significant association between methylation of the ESR1 promoter, and methylation at CDH1, TRbeta1, GSTP1, and CCND2 loci (P < 0.03). Methylated status of the BRCA1 promoter was inversely correlated with methylation at the RARbeta2 locus (P < 0.03). Our results suggest a nonrandom distribution for promoter hypermethylation in sporadic breast cancer, with tumor subsets characterized by aberrant methylation of specific cancer-related genes. These breast cancer subgroups may represent separate biological entities with potential differences in sensitivity to therapy, occurrence of metastasis, and overall prognosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049707708

Download citation: RISBibTeXText

PMID: 15328171

DOI: 10.1158/1078-0432.ccr-04-0555


Related references

Aberrant promoter methylation of cancer-related genes in human breast cancer. Oncology Letters 12(6): 5145-5155, 2016

Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene. 17(14): 1807-1812,. 8, 1998

BRCA1 inactivation in sporadic breast cancer is associated with aberrant cytosine methylation and alterations in chromatin structure of the BRCA1 CpG island promoter. Proceedings of the American Association for Cancer Research Annual Meeting 40: 443, 1999

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. International Journal of Cancer 124(7): 1727-1735, 2009

Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. Plos one 5(1): E8777, 2010

Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes. Breast Cancer Research 19(1): 19, 2017

Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report. Journal of Medical Case Reports 5: 516, 2011

Aberrant methylation of ATG2B, ATG4D, ATG9A and ATG9B CpG island promoter is associated with decreased mRNA expression in sporadic breast carcinoma. Gene 590(2): 285-292, 2016

Aberrant genes promoter methylation in neural crest-derived tumors. International Journal of Biological Markers 27(4): E389-E394, 2012

Aberrant CBFA2T3B gene promoter methylation in breast tumors. Molecular Cancer 3: 22, 2004

Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Molecular Oncology 5(1): 61-76, 2011

Aberrant methylation of tumor suppressor genes in sporadic cutaneous cancer. Modern Pathology 16(1): 95A, 2003

Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer. Journal of Applied Genetics 56(2): 185-192, 2015

T2070 The Promoter Polymorphism of Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2) Gene Affects the Aberrant Promoter Methylation of Tumor-Related Genes in Gastric Epithelium. Gastroenterology 134(4): A-612-A-613, 2008

Methylation of the BRCA1 promoter in sporadic breast cancer related to BRCA1 copy number and pathologic features. Proceedings of the American Association for Cancer Research Annual Meeting 44: 987-988, 2003